Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Jun-24 9:33 PM View:  | Kreis Leslie W. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant Duplicate | 8,500 | -- | -- | < 1% 6.01M to 6.01M | |
| 11-Jun-24 6:46 PM View: | Richstone Ellen B Director | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant | 8,500 | -- | -- | 53% 16.0K to 24.5K | |
| 11-Jun-24 6:46 PM View: | Monia Brett P Director | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant | 8,500 | -- | -- | 142% 6.0K to 14.5K | |
| 11-Jun-24 6:47 PM View: | Wallace Peggy Director | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant | 8,500 | -- | -- | 19% 43.96K to 52.46K | |
| 11-Jun-24 9:32 PM View: | Fletcher Aaron G.L. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant | 8,500 | -- | -- | < 1% 6.01M to 6.01M | |
| 11-Jun-24 6:47 PM View: | Khattar Jack A. Director | Cognition Therapeutics Inc (CGTX) | 07-Jun-24 | Grant | 8,500 | -- | -- | 142% 6.0K to 14.5K | |
| 03-May-24 4:07 PM View: | Doyle John Brendan Chief Financial Officer | Cognition Therapeutics Inc (CGTX) | 01-May-24 | Payment of Exercise | 8,699 | $1.95 | $16,963.10 | (7%) 129.82K to 121.13K | |
| 14-Mar-24 4:34 PM View: | Ricciardi Lisa CEO & President Director | Cognition Therapeutics Inc (CGTX) | 14-Mar-24 | Private Purchase | 5,700 | $1.75 | $9,975.00 | 2% 285.64K to 291.35K | |
| 20-Feb-24 4:13 PM View: | Caggiano Anthony Chief Medical Officer | Cognition Therapeutics Inc (CGTX) | 15-Feb-24 | Grant | 60,000 | -- | -- | 74% 81.63K to 141.63K | |
| 20-Feb-24 4:13 PM View: | Doyle John Brendan Chief Financial Officer | Cognition Therapeutics Inc (CGTX) | 15-Feb-24 | Grant | 20,000 | -- | -- | 18% 109.82K to 129.82K | |
| 20-Feb-24 4:12 PM View: | Ricciardi Lisa CEO & President Director | Cognition Therapeutics Inc (CGTX) | 15-Feb-24 | Grant | 75,000 | -- | -- | 36% 210.65K to 285.64K | |
| 09-Feb-24 7:11 PM View: | Ricciardi Lisa CEO & President Director | Cognition Therapeutics Inc (CGTX) | 03-Feb-24 | Payment of Exercise | 27,828 | $2.29 | $63,726.10 | (12%) 238.47K to 210.65K | |
| 09-Feb-24 7:12 PM View: | Caggiano Anthony Chief Medical Officer | Cognition Therapeutics Inc (CGTX) | 03-Feb-24 | Payment of Exercise | 12,777 | $2.29 | $29,259.30 | (14%) 94.41K to 81.63K | |
| 13-Nov-23 9:48 AM View: | Kreis Leslie W. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 08-Nov-23 | Grant | 500,095 | $1.05 | $525,100.00 | 9% 5.51M to 6.01M | |
| 13-Nov-23 9:47 AM View: | Fletcher Aaron G.L. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 08-Nov-23 | Grant Duplicate | 500,095 | $1.05 | $525,100.00 | 9% 5.51M to 6.01M | |
| 13-Jun-23 5:39 PM View: | Monia Brett P Director | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 13-Jun-23 10:00 PM View: | Kreis Leslie W. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant Duplicate | 6,000 | -- | -- | < 1% 5.5M to 5.51M | |
| 13-Jun-23 5:37 PM View: | Khattar Jack A. Director | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 13-Jun-23 10:00 PM View: | Fletcher Aaron G.L. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant | 6,000 | -- | -- | < 1% 5.5M to 5.51M | |
| 13-Jun-23 5:38 PM View: | Richstone Ellen B Director | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 13-Jun-23 5:38 PM View: | Wallace Peggy Director | Cognition Therapeutics Inc (CGTX) | 09-Jun-23 | Grant | 6,000 | -- | -- | 16% 37.96K to 43.96K | |
| 03-May-23 4:20 PM View: | Doyle John Brendan Chief Financial Officer | Cognition Therapeutics Inc (CGTX) | 01-May-23 | Grant | 109,824 | -- | -- | 100% 0 to 109.82K | |
| 07-Feb-23 4:05 PM View: | Caggiano Anthony Chief Medical Officer | Cognition Therapeutics Inc (CGTX) | 03-Feb-23 | Grant | 94,406 | -- | -- | 100% 0 to 94.41K | |
| 07-Feb-23 4:05 PM View: | Ricciardi Lisa CEO & President Director | Cognition Therapeutics Inc (CGTX) | 03-Feb-23 | Grant | 213,973 | -- | -- | 873% 24.5K to 238.47K | |
| 29-Nov-22 4:57 PM View: | Richstone Ellen B Director | Cognition Therapeutics Inc (CGTX) | 29-Nov-22 | Private Purchase | 10,000 | $2.65 | $26,550.00 | 100% 0 to 10.0K | |
| 29-Nov-22 7:02 AM View: | Fletcher Aaron G.L. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 28-Nov-22 | Private Purchase Duplicate | 16,064 | $2.65 | $42,564.80 | < 1% 5.48M to 5.5M | |
| 29-Nov-22 7:00 AM View: | Kreis Leslie W. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 28-Nov-22 | Private Purchase | 16,064 | $2.65 | $42,564.80 | < 1% 5.48M to 5.5M | |
| 17-Nov-22 7:00 AM View: | Kreis Leslie W. Director | Cognition Therapeutics Inc (CGTX) | 16-Nov-22 | Private Purchase | 71,000 | $1.40 | $99,400.00 | 1% 5.41M to 5.48M | |
| 17-Nov-22 7:00 AM View: | Fletcher Aaron G.L. Director | Cognition Therapeutics Inc (CGTX) | 16-Nov-22 | Private Purchase Duplicate | 71,000 | $1.40 | $99,400.00 | 1% 5.41M to 5.48M | |
| 16-Nov-22 8:30 AM View: | Wallace Peggy Director | Cognition Therapeutics Inc (CGTX) | 15-Nov-22 | Private Purchase | 12,500 | $1.20 | $15,000.00 | 49% 25.46K to 37.96K | |
| 16-Nov-22 8:31 AM View: | Ricciardi Lisa CEO & President Director | Cognition Therapeutics Inc (CGTX) | 15-Nov-22 | Private Purchase | 12,000 | $1.30 | $15,600.00 | 96% 12.5K to 24.5K | |
| 16-Nov-22 7:00 AM View: | Fletcher Aaron G.L. Director | Cognition Therapeutics Inc (CGTX) | 15-Nov-22 | Private Purchase Duplicate | 1,500,000 | $1.20 | $1,800,000.00 | 38% 3.91M to 5.41M | |
| 16-Nov-22 6:59 AM View: | Kreis Leslie W. Director | Cognition Therapeutics Inc (CGTX) | 15-Nov-22 | Private Purchase | 1,500,000 | $1.20 | $1,800,000.00 | 38% 3.91M to 5.41M | |
| 29-Sep-22 4:01 PM View: | Wallace Peggy Director | Cognition Therapeutics Inc (CGTX) | 27-Sep-22 | Acquisition (other) | 22,461 | -- | -- | 749% 3.0K to 25.46K | |
| 29-Sep-22 4:02 PM View: | Golden Seeds Cognition Ther... 10% Owner | Cognition Therapeutics Inc (CGTX) | 27-Sep-22 | Disposition (other) | 2,489,680 | -- | -- | (100%) 2.49M to 0 | |
| 15-Oct-21 9:51 PM View: | Ogden Cap Associates, LLC 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Exercise (in-the money or at-the-money) | 27,471 | $0.03 | $879.07 | 1% 2.18M to 2.21M | |
| 15-Oct-21 9:51 PM View: | Golden Seeds Cognition Ther... 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Exercise (in-the money or at-the-money) | 12,276 | $0.03 | $392.83 | < 1% 2.48M to 2.49M | |
| 15-Oct-21 9:54 PM View: | Bios Memory Spv I, Lp 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Sale Duplicate | 90 | $12.00 | $1,083.36 | (< 1%) 3.91M to 3.91M | |
| 15-Oct-21 9:51 PM View: | Fletcher Aaron G.L. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Sale | 90 | $12.00 | $1,083.36 | (< 1%) 3.91M to 3.91M | |
| 15-Oct-21 9:02 PM View: | Breedlove Mark H. Director | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Sale | 12 | $12.00 | $140.88 | (< 1%) 412.06K to 412.05K | |
| 15-Oct-21 9:54 PM View: | Bios Memory Spv I, Lp 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Conversion | 2,265,420 | -- | -- | 159% 1.42M to 3.69M | |
| 15-Oct-21 9:54 PM View: | Bios Memory Spv I, Lp 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Exercise (in-the money or at-the-money) Duplicate | 33,495 | $0.03 | $1,071.84 | < 1% 3.88M to 3.91M | |
| 15-Oct-21 9:51 PM View: | Fletcher Aaron G.L. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Exercise (in-the money or at-the-money) | 33,495 | $0.03 | $1,071.84 | < 1% 3.88M to 3.91M | |
| 25-Oct-21 8:18 PM View: | Wallace Peggy Director | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Purchase | 3,000 | $12.00 | $36,000.00 | 100% 0 to 3.0K | 0% |
| 14-Oct-21 9:46 PM View: | Ricciardi Lisa CEO & President Director | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Purchase | 12,500 | $12.00 | $150,000.00 | 100% 0 to 12.5K | 2% |
| 15-Oct-21 9:51 PM View: | Ogden Cap Associates, LLC 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Sale | 74 | $12.00 | $888.60 | (< 1%) 2.21M to 2.21M | |
| 15-Oct-21 9:51 PM View: | Golden Seeds Cognition Ther... 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Sale | 33 | $12.00 | $397.08 | (< 1%) 2.49M to 2.49M | |
| 15-Oct-21 9:54 PM View: | Bios Memory Spv I, Lp 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Purchase Duplicate | 190,000 | $12.00 | $2,280,000.00 | 5% 3.69M to 3.88M | |
| 15-Oct-21 9:51 PM View: | Fletcher Aaron G.L. Director 10% Owner | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Purchase | 190,000 | $12.00 | $2,280,000.00 | 5% 3.69M to 3.88M | |
| 14-Oct-21 9:46 PM View: | O'Brien James Michael Chief Financial Officer | Cognition Therapeutics Inc (CGTX) | 13-Oct-21 | Market Purchase | 5,000 | $12.00 | $60,000.00 | 100% 0 to 5.0K | 2% |
